TipRanks
Advertisement
Advertisement

ARGX Stock Latest News

Argenx Earnings Call: VYVGART Surge Fuels 2027 Pivot
Company AnnouncementsArgenx Earnings Call: VYVGART Surge Fuels 2027 Pivot
8h ago
ARGX
Citi adds ‘upside 90-day catalyst watch’ on Argenx
PremiumThe Fly
Citi adds ‘upside 90-day catalyst watch’ on Argenx
2d ago
ARGX
Argenx price target lowered to $1,025 from $1,100 at RBC Capital
PremiumThe Fly
Argenx price target lowered to $1,025 from $1,100 at RBC Capital
3d ago
ARGX
Argenx (ARGX) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Argenx (ARGX) Q3 Earnings Cheat Sheet
3d ago
ARGX
Argenx reports ALKIVIA study meets primary endpoint
PremiumThe Fly
Argenx reports ALKIVIA study meets primary endpoint
4d ago
ARGX
Argenx price target raised to $1,356 from $1,355 at Wells Fargo
PremiumThe FlyArgenx price target raised to $1,356 from $1,355 at Wells Fargo
9d ago
ARGX
Argenx price target lowered to $1,038 from $1,100 at Oppenheimer
Premium
The Fly
Argenx price target lowered to $1,038 from $1,100 at Oppenheimer
11d ago
ARGX
Argenx price target raised to $1,157 from $1,136 at BofA
Premium
The Fly
Argenx price target raised to $1,157 from $1,136 at BofA
11d ago
ARGX
Argenx price target lowered to $1,140 from $1,250 at Morgan Stanley
PremiumThe Fly
Argenx price target lowered to $1,140 from $1,250 at Morgan Stanley
14d ago
ARGX
Argenx price target lowered to $1,078 from $1,175 at Evercore ISI
PremiumThe Fly
Argenx price target lowered to $1,078 from $1,175 at Evercore ISI
14d ago
ARGX
Argenx price target lowered to $823 from $932 at Baird
PremiumThe Fly
Argenx price target lowered to $823 from $932 at Baird
14d ago
ARGX
Argenx price target lowered to $1,355 from $1,415 at Wells Fargo
PremiumThe Fly
Argenx price target lowered to $1,355 from $1,415 at Wells Fargo
14d ago
ARGX
First Tracks Biotherapeutics price target raised to $62 from $55 at Wells Fargo
PremiumThe FlyFirst Tracks Biotherapeutics price target raised to $62 from $55 at Wells Fargo
14d ago
ARGX
TEVA
Argenx falls -14.4%
Premium
The Fly
Argenx falls -14.4%
15d ago
ARGX
Immunovant down after Argenx study fails in Sjogren’s disease
Premium
The Fly
Immunovant down after Argenx study fails in Sjogren’s disease
15d ago
ARGX
IMVT
Argenx has ‘good news and bad news’ day, says H.C. Wainwright
PremiumThe Fly
Argenx has ‘good news and bad news’ day, says H.C. Wainwright
15d ago
ARGX
IMVT
Argenx falls -12.4%
PremiumThe Fly
Argenx falls -12.4%
15d ago
ARGX
Argenx to discontinue UNITY study of efgartigimod subcutaneous
PremiumThe Fly
Argenx to discontinue UNITY study of efgartigimod subcutaneous
15d ago
ARGX
Argenx announces FB102 study met its primary endpoint
PremiumThe Fly
Argenx announces FB102 study met its primary endpoint
15d ago
ARGX
Halozyme expands global collaboration and license agreement with Argenx
PremiumThe FlyHalozyme expands global collaboration and license agreement with Argenx
16d ago
ARGX
HALO
Argenx Unveils New VYVGART and Pipeline Data at AANEM and MGFA
Premium
Company Announcements
Argenx Unveils New VYVGART and Pipeline Data at AANEM and MGFA
24d ago
6K
ARGX
Ginkgo Bioworks, Apheris announce kick off of Antibody Developability Consortium
Premium
The Fly
Ginkgo Bioworks, Apheris announce kick off of Antibody Developability Consortium
24d ago
DNA
TAK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >